GAD2 and epilepsy: Furthermore, considering the relatively high comorbidity of DM1 in patients with epilepsy (21), the clinical relevance of GAD65-Abs for the neuropsychiatric disease (mainly epilepsy in this case) in these patients remains doubtful.